vicadrostat / empagliflozin combination 1

DRUG2 trials

Sponsors

Boehringer Ingelheim, University Medical Center Groningen

Conditions

CKDCardiovascular DiseasesHealthyHeart Failure

Phase 1

A Study in Healthy People to Test How 2 Different Formulations of a Combination Treatment (Vicadrostat and Empagliflozin) Are Taken up in the Body and How Food Influences the Amount of the Medicines in the Blood

CompletedNCT07133399

Boehringer IngelheimHealthy

Start: 2025-09-08End: 2025-10-22Updated: 2026-01-06

Phase 2

Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)

RecruitingNCT07304817

University Medical Center GroningenCardiovascular Diseases, CKD, Heart Failure

Start: 2026-04-10End: 2028-02-01Target: 100Updated: 2026-04-16